Surgery Partners, Inc. (SGRY) Earnings Call Analysis

NASDAQ · Healthcare · Medical Care Facilities

17/25

Growth 4 Margin 3 Expansion 3 Platform 3 Financial 4

latest quarter score

Earnings Reports

17
Surgery Partners (SGRY) Q2 2026: Idaho Falls Divestiture Sharpens Focus on High-Acuity Outpatient Growth
August 10, 2026
21
Surgery Partners (SGRY) Q1 2026: Musculoskeletal Joints Up 15%, Robotics and DeNovos Anchor Growth Shift
May 05, 2026
10
Surgery Partners (SGRY) Q4 2025: Commercial Payer Mix Falls 370bps, Spotlighting Margin Reset
March 03, 2026
14
Surgery Partners (SGRY) Q3 2025: $20M Guidance Cut Highlights M&A and Payer Mix Timing Drag
November 10, 2025
21
Surgery Partners (SGRY) Q2 2025: Orthopedic Joint Procedures Surge 26% as De Novo Pipeline Expands
August 05, 2025
22
Surgery Partners (SGRY) Q1 2025: Orthopedic Joint Cases Surge 22%, Fueling High-Acuity Growth
July 07, 2025
Surgery Partners (SGRY) Q4 2024: 17.5% Revenue Growth Highlights Robust Organic and Acquisition-Driven Expansion
March 03, 2025

Browse all companies